Literature DB >> 8798734

Amyloid beta peptide formation in cell-free preparations. Regulation by protein kinase C, calmodulin, and calcineurin.

F Desdouits1, J D Buxbaum, J Desdouits-Magnen, A C Nairn, P Greengard.   

Abstract

Amyloid beta peptide (Abeta) is a short peptide that is the major constituent of the amyloid plaques and cerebrovascular amyloid deposits found in Alzheimer's disease. The lack of availability of a cell-free system in which to study Abeta formation has limited our understanding of the molecular mechanisms involved in its production. We report here the reconstitution of such a cell-free system. The reconstituted Abeta formation was temperature-dependent and required ATP. Preincubation with purified protein kinase C (PKC) induced a pronounced inhibition of Abeta formation, similar to that observed in intact cells upon stimulation of PKC. The calmodulin antagonists W-7 and trifluoperazine inhibited Abeta formation and enhanced the action of PKC in both the cell-free system and intact cells. A role for the calcium/calmodulin-activated protein phosphatase calcineurin in the regulation of Abeta formation was demonstrated using a specific peptide inhibitor of calcineurin in vitro as well as cyclosporin A, a cell-permeant inhibitor of calcineurin, in intact cells. Our results suggest that a single substrate might mediate opposing actions of PKC and calcineurin in the regulation of Abeta formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798734     DOI: 10.1074/jbc.271.40.24670

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Calcium induces expression of cytoplasmic gelsolin in SH-SY5Y and HEK-293 cells.

Authors:  Lina Ji; Abha Chauhan; Ved Chauhan
Journal:  Neurochem Res       Date:  2010-03-26       Impact factor: 3.996

3.  Notch-inducible hyperphosphorylated CREB and its ultradian oscillation in long-term memory formation.

Authors:  Jiabin Zhang; Christopher J Little; Daniel M Tremmel; Jerry C P Yin; Cedric S Wesley
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

4.  Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation.

Authors:  H Xu; D Sweeney; R Wang; G Thinakaran; A C Lo; S S Sisodia; P Greengard; S Gandy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

Review 6.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path.

Authors:  J D Buxbaum; G Thinakaran; V Koliatsos; J O'Callahan; H H Slunt; D L Price; S S Sisodia
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method.

Authors:  Christian Hödar; Rodrigo Assar; Marcela Colombres; Andrés Aravena; Leonardo Pavez; Mauricio González; Servet Martínez; Nibaldo C Inestrosa; Alejandro Maass
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

Review 9.  Protein phosphorylation and APP metabolism.

Authors:  Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

10.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.